Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-30

Clinical Trial Update: Treatment of Nosebleeds in the Emergency Department With Powder Tranexamic Acid [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating tranexamic acid powder for epistaxis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Dr. Anne Conlin | Conditions: Epistaxis Nosebleed | Phase 1, Phase 2 | Status: RECRUITING